Array BioPharma, Inc. (NASDAQ:ARRY)
A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
NuclearSteve
(58.59)
Submitted: 4/12/2013 2:08:01 PM :
Start Price:
$5.44
ARRY Score:
-13.00
Baker brothers increased their holding.
Recs
bichon2
(77.52)
Submitted: 3/6/2013 11:59:45 AM :
Start Price:
$4.32
ARRY Score:
+7.35
Great drug to treat braf mutation cancers. Also good results in multiple myeloma .
Recs
CarlosDK
(75.81)
Submitted: 1/23/2013 7:57:05 AM :
Start Price:
$3.99
ARRY Score:
-13.20
TOS: TOP HS pattern
Recs
bIlluminati
(31.16)
Submitted: 3/2/2012 3:52:37 PM :
Start Price:
$2.86
ARRY Score:
-52.27
Not profitable. Book value down to $.17/share, The dead cat bounce from early February is over.
Recs
tesst
(< 20)
Submitted: 2/7/2012 3:42:20 PM :
Start Price:
$3.29
ARRY Score:
+27.80
Has bottomed and it is all up from here
Recs
solanZRaider
(< 20)
Submitted: 4/26/2011 3:19:12 PM :
Start Price:
$3.06
ARRY Score:
+38.88
Momentum21 & usubanas
Recs
rocknpopstocks
(< 20)
Submitted: 1/28/2011 12:32:42 PM :
Start Price:
$2.82
ARRY Score:
+46.29
Could show serious growth of this decade.
Recs
cprpm
(< 20)
Submitted: 10/13/2010 4:09:59 PM :
Start Price:
$3.53
ARRY Score:
+0.07
Array has been able to survive the toughest of times, I feel it's matter of time.
Recs
21popsontop
(< 20)
Submitted: 1/28/2010 10:21:53 AM :
Start Price:
$2.51
ARRY Score:
+45.54
Has always had that longshot look, and now we see the big boys taking them out for dinner and paying for friendship, advise and technology expertise. Looks much better than DNDN for sure and even has real products on the market and several more in the oven. One to watch.
Recs
Recs
redwings103149
(29.99)
Submitted: 9/15/2009 11:03:37 PM :
Start Price:
$2.84
ARRY Score:
+17.75
What a great price to get into this stock. Well little history on arry was that they have had a hugeeee pipeline but have been blessed with some terrible along with a trial 3 data result that did not meet its ends. Away from the bad they have four game changers due within the next 6months so spec alone will hype this baby up eventually.
Recs
shinier
(30.02)
Submitted: 9/10/2009 6:31:14 PM :
Start Price:
$2.83
ARRY Score:
+16.72
Loss-making, but these small pharma's are a gamble. One hit is all it takes.
Recs
GrandTheftHemi
(< 20)
Submitted: 5/7/2009 9:57:48 PM :
Start Price:
$3.12
ARRY Score:
-22.41
At lower end of trading range with possible DRIVERS coming in Summer of 2009. 4.75 a share would make me smile but anything higher would make me Happy...not a bad company as BIOS go.
Recs
TheBigLab
(26.64)
Submitted: 5/5/2009 1:03:23 PM :
Start Price:
$3.07
ARRY Score:
-23.24
Bio is the next big run after financials and alt energy....its coming.
Recs
rxedoh26
(53.81)
Submitted: 1/31/2009 10:28:16 PM :
Start Price:
$3.94
ARRY Score:
-79.55
going up eventually
Recs
TMFBiologyFool
(99.13)
Submitted: 10/13/2008 5:43:44 PM :
Start Price:
$5.14
ARRY Score:
-64.82
Good pipeline. Market is overrating the risk.
Recs
bsmith47
(33.95)
Submitted: 4/17/2008 11:41:07 AM :
Start Price:
$6.74
ARRY Score:
-52.07
biotech darling will be bought out eventually by a big pharma for growth.
Recs
tomk0508
(86.48)
Submitted: 2/4/2008 12:22:59 AM :
Start Price:
$6.49
ARRY Score:
-46.87
This is an interesting small cap company with a decent drug pipeline as well as some very intriguing technology for drug development. It is not clear that they have a winner in the pipeline yet but they do have one of the best drug development platforms available. Their platform allows development that is rapid and inexpensive and this should enable the company to excell over the longer term as they have solid scientific expertise in house.
Recs
PIcolano
(42.10)
Submitted: 12/21/2007 3:38:28 PM :
Start Price:
$8.67
ARRY Score:
-58.59
The depth of Array's pipeline is similar to Exelexis' pipeline, and should pay off handsomely for both companies over the long haul...
Recs
SavvyMoneyMan
(79.78)
Submitted: 10/17/2007 4:28:00 PM :
Start Price:
$11.95
ARRY Score:
-70.60
I decided to Bail on Excel after the failed drug trial so I ended that pick. Then the RuleBreaker newsletter gave me another drug company to replace excel. I really like what rulebreaker says, subscribe to get the details.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 26 : 1 2 Next »